Doç. Dr. Berrin Yalçın

Survival in Synchronous Versus Metachronous Bladder and Prostate Cancer

Archivos Españoles de Urología, 2026

DOI 10.56434/j.arch.esp.urol.20267905.93 PMID 42438875 Frei zugänglicher VolltextQuelle: OpenAlex

Qualitative Interferon-γ Release Assay for Predicting Response to BCG Instillations in Bladder Cancer

Archivos Españoles de Urología, 2025

DOI 10.56434/j.arch.esp.urol.20257808.133 PMID 41111372 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Predictive Value of Systemic Inflammatory Markers in the Prognosis of Prostate Cancer with Variant Histology.

Urology journal./Urology jornal., 2025

DOI 10.22037/uj.v22i.8378 PMID 40684276 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Survival in Synchronous Versus Metachronous Bladder & Prostate Cancer

Research Square, 2025

DOI 10.21203/rs.3.rs-7579205/v1 Frei zugänglicher VolltextQuelle: ORCID

Hemoglobin Level as a Prognostic Factor of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer

Istanbul Medical Journal, 2024

DOI 10.4274/imj.galenos.2024.35902 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

Qualitative Interferon-γ Release Assay for Predicting Response to BCG instillations in Bladder Cancer

Research Square, 2024

DOI 10.21203/rs.3.rs-4357424/v1 Frei zugänglicher VolltextQuelle: ORCID

Synchronous/Metachronous Bilateral Breast Cancer: a Long-Term Follow-up Single-Center Experience

Indian Journal of Surgery, 2024

DOI 10.1007/s12262-023-03965-z 1 Zitation (OpenAlex) Quelle: ORCID

Discriminant Efficacy of mpMRI for Variant Pathology Associated with Prostate Adenocarcinoma.

Urology journal./Urology jornal., 2023

DOI 10.22037/uj.v20i.7468 PMID 36840448 Frei zugänglicher VolltextQuelle: OpenAlex

Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish Society for Radiation Oncology (TROD 05-002)

Strahlentherapie und Onkologie, 2023

DOI 10.1007/s00066-023-02154-x PMID 37796342 3 Zitationen (Europe PMC) Quelle: OpenAlex

Oncological outcomes for encapsulated papillary carcinoma of the breast: Multicentric study of Turkish Society for Radiation Oncology breast cancer study group (TROD 06–014 study)

Asia-Pacific Journal of Clinical Oncology, 2023

DOI 10.1111/ajco.13893 PMID 36464924 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

Discriminant Efficacy of mpMRI for Variant Pathology Associated with Prostate Adenocarcinoma

UROLOGY JOURNAL, 2023

DOI 10.22037/uj.v20i.7468] Quelle: ORCID

PRETREATMENT PROGNOSTIC NUTRITIONAL INDEX AND ALBUMIN/GLOBULIN RATIO ASSESSMENT AS A LARYNGEAL CANCER SURVIVAL PREDICTOR

ACTA MEDICA MEDITERRANEA, 2023

DOI 10.19193/0393-6384_2023_1_1 Quelle: ORCID

Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study

Critical Care, 2020

DOI 10.1186/s13054-020-03215-8 PMID 32771054 44 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Comparation Between Radiotherapy Alone and Weekly Cisplatin and Concurrent Radiotherapy Application in Locally Advanced Cervix Cancer

ISTANBUL MEDICAL JOURNAL, 2009

Quelle: ORCID

Evalutian of Prognostic Factors in Patients Recieved Adjuvant Radiotherapy After Mastectomy

ISTANBUL MEDICAL JOURNAL, 2009

Quelle: ORCID